Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Nanotechnology provides effective methods for precisely delivering chemotherapeutics to cancer cells, thereby improving efficacy and reducing off-target side effects. The targeted delivery of nanoscale chemotherapeutics is accomplished by two different approaches, namely the exploitation of leaky tu...
Main Authors: | Mamta Kumari, Amitabha Acharya, Praveen Thaggikuppe Krishnamurthy |
---|---|
Format: | Article |
Language: | English |
Published: |
Beilstein-Institut
2023-09-01
|
Series: | Beilstein Journal of Nanotechnology |
Subjects: | |
Online Access: | https://doi.org/10.3762/bjnano.14.75 |
Similar Items
-
Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
by: Sulltana Jahan, et al.
Published: (2021-01-01) -
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
by: Alberto Juan, et al.
Published: (2020-08-01) -
Marine Antibody–Drug Conjugates: Design Strategies and Research Progress
by: Yu-Jie Wang, et al.
Published: (2017-01-01) -
Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
by: Chi Hun Song, et al.
Published: (2023-11-01) -
Antibody–Drug Conjugate to Treat Meningiomas
by: Kai Chen, et al.
Published: (2021-05-01)